The successful management of prostate cancer requires early detection, appropriate risk assessment, and optimum treatment. An unmet goal of prostate cancer imaging is to differentiate indolent from aggressive tumors, as treatment may vary for different grades of the disease. Different modalities have been tested to diagnose, stage, and monitor prostate cancer during therapy. This review briefly describes the key clinical issues in prostate cancer imaging and therapy and summarizes the various new imaging modalities and agents in use and on the horizon. Copyright © 2009 by the Society of Nuclear Medicine, Inc.
CITATION STYLE
Zaheer, A., Cho, S. Y., & Pomper, M. G. (2009, September 1). New agents and techniques for imaging prostate cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.109.061838
Mendeley helps you to discover research relevant for your work.